I

InnoSIGN

16 employees

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.

Basic info

Industry

hospitals and health care

Sectors

Biotechnology
precision medicine
oncology
Life Science
oncosignal
signaling pathways
molecular diagnostics
diagnostics
genomics
Medical
biotech

Date founded

2022

Funding rounds raised

Total raised

$8M

from 3 investors over 3 rounds

I

InnoSIGN raised $8M on March 22, 2022

Investors: Life Science Angels, Casdin Capital, LLC and Thuja Capital

FAQ